{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T21:25:56Z","timestamp":1789593956808,"version":"build-2803163510"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hereditas"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      Cisplatin (DDP) is the major chemotherapeutic drug used to treat gastric cancer (GC). However, DDP-associated side effects and resistance chemoresistance have limited its clinical application. Psoralidin (PSO) is the main extract of\n                      <jats:italic>Psoralea corylifolia<\/jats:italic>\n                      and has antitumor effects. The present study is designed to investigate the antitumor functions and mechanisms of PSO and DDP in GC.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      GC cells (HGC-27 and MKN-45 cells) were treated with PSO (2.5 to 120 \u00b5M) and\/or DDP. A CCK-8 assay, colony formation assay, and EdU staining were used to test cell proliferation. Cell migration and invasion were tested via a transwell assay. An in vivo assay in nude mice was carried out to analyze the influence of PSO and DDP on tumor growth. H&amp;E staining was conducted to test the histopathological changes of organs and tumor tissues. Ferroptosis-associated indicators, including GSH, MDA, Fe\n                      <jats:sup>2+<\/jats:sup>\n                      levels, were examined. Western\n                      <jats:italic>blotting<\/jats:italic>\n                      was conducted to determine the profiles of ACSL4, GPX4, AIFM2, and SLC7A11.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>PSO impeded GC cell proliferation, migration, invasion, and growth in vivo. PSO exhibited no significant toxic effects on organs and mitigated DDP-mediated liver and kidney injuries. The combination of PSO and DDP exhibited enhanced inhibitory functions. PSO and DDP can significantly promote GC cell ferroptosis. Moreover, PSO promoted ACSL4 expression and suppressed GPX4, AIFM2, and SLC7A11.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The combination of PSO and DDP has synergistic antitumor effects on GC cells by inducing ACSL4-mediated ferroptosis. PSO may serve as a nontoxic adjuvant to enhance DDP\u2019s efficacy and reduce side effects in GC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s41065-025-00591-5","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T11:17:58Z","timestamp":1762255078000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The synergistic antitumor effects of psoralidin and cisplatin in gastric cancer by inducing ACSL4-mediated ferroptosis"],"prefix":"10.1186","volume":"162","author":[{"given":"Ling","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhua","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihong","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,4]]},"reference":[{"issue":"3","key":"591_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"591_CR2","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1002\/jso.26844","volume":"125","author":"JY Xia","year":"2022","unstructured":"Xia JY, Aadam AA. Advances in screening and detection of gastric cancer. J Surg Oncol. 2022;125(7):1104\u20139.","journal-title":"J Surg Oncol"},{"issue":"5","key":"591_CR3","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1111\/apt.17872","volume":"59","author":"I Ligato","year":"2024","unstructured":"Ligato I, Dottori L, Sbarigia C, et al. Systematic review and meta-analysis: risk of gastric cancer in patients with first-degree relatives with gastric cancer. Aliment Pharmacol Ther. 2024;59(5):606\u201315.","journal-title":"Aliment Pharmacol Ther"},{"key":"591_CR4","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cancergen.2024.06.002","volume":"286\u2013287","author":"D Sonkin","year":"2024","unstructured":"Sonkin D, Thomas A, Teicher BA. Cancer treatments: Past, present, and future. Cancer Genet. 2024;286\u2013287:18\u201324.","journal-title":"Cancer Genet"},{"issue":"1","key":"591_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2023.103819","volume":"29","author":"MS Khan","year":"2024","unstructured":"Khan MS, Jaswanth Gowda BH, Almalki WH, Singh T, Sahebkar A, Kesharwani P. Unravelling the potential of mitochondria-targeted liposomes for enhanced cancer treatment. Drug Discov Today. 2024;29(1):103819.","journal-title":"Drug Discov Today"},{"key":"591_CR6","doi-asserted-by":"publisher","DOI":"10.1177\/15330338221090353","volume":"21","author":"T Li","year":"2022","unstructured":"Li T, He Y, Zhong Q, Yu J, Chen X. Advances in treatment models of advanced gastric cancer. Technol Cancer Res Treat. 2022;21:15330338221090353.","journal-title":"Technol Cancer Res Treat"},{"issue":"1","key":"591_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-025-01698-y","volume":"18","author":"Y Chen","year":"2025","unstructured":"Chen Y, Jia K, Xie Y, Yuan J, Liu D, Jiang L, et al. The current landscape of gastric cancer and gastroesophageal junction cancer diagnosis and treatment in China: a comprehensive nationwide cohort analysis. J Hematol Oncol. 2025;18(1):42.","journal-title":"J Hematol Oncol"},{"issue":"4","key":"591_CR8","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1111\/jgh.14024","volume":"33","author":"F Sun","year":"2018","unstructured":"Sun F, Sun H, Mo X, et al. Increased survival rates in gastric cancer, with a narrowing gender gap and widening socioeconomic status gap: a period analysis from 1984 to 2013. J Gastroenterol Hepatol. 2018;33(4):837\u201346.","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"591_CR9","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1093\/annonc\/mdu472","volume":"26","author":"Y Yamada","year":"2015","unstructured":"Yamada Y, Higuchi K, Nishikawa K, Gotoh M, Fuse N, Sugimoto N, et al. Phase III study comparing oxaliplatin plus S-1 with cisplatin plus S-1 in chemotherapy-na\u00efve patients with advanced gastric cancer. Ann Oncol. 2015;26(1):141\u20138.","journal-title":"Ann Oncol"},{"issue":"3","key":"591_CR10","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S1470-2045(08)70035-4","volume":"9","author":"W Koizumi","year":"2008","unstructured":"Koizumi W, Narahara H, Hara T, Takagane A, Akiya T, Takagi M, et al. S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet Oncol. 2008;9(3):215\u201321.","journal-title":"Lancet Oncol"},{"issue":"12","key":"591_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/antiox13121578","volume":"13","author":"O Rose","year":"2024","unstructured":"Rose O, Croonenberg T, Clemens S, Hinteregger T, Eppacher S, Huber-Cantonati P, et al. Cisplatin-induced hearing loss, oxidative stress, and antioxidants as a therapeutic strategy-a state-of-the-art review. Antioxidants. 2024;13(12):1578.","journal-title":"Antioxidants"},{"key":"591_CR12","doi-asserted-by":"publisher","unstructured":"Boruah P, Kumar A, Dutt P, Mahajan O, Shabbir S, Parab M, Gupta PP, Bhutta ZA. Combined effects of Terminalia Bellirica and Glycyrrhiza glabra on ameliorating cisplatin-induced nephrotoxicity in Swiss albino mice. Nat Prod Res. 2024:1\u20139. https:\/\/doi.org\/10.1080\/14786419.2024.2447048. Epub ahead of print.","DOI":"10.1080\/14786419.2024.2447048"},{"key":"591_CR13","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.103904.3","volume":"13","author":"S Zhao","year":"2025","unstructured":"Zhao S, Lin J, Zhu B, Jin Y, Dong Q, Ruan X, et al. NOLC1 suppresses immunochemotherapy by inhibiting p53-mediated ferroptosis in gastric cancer. Elife. 2025;13:RP103904.","journal-title":"Elife"},{"issue":"1","key":"591_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s41065-025-00508-2","volume":"162","author":"L Zhou","year":"2025","unstructured":"Zhou L, Xu B, Li B. Carnosic acid enhances cisplatin sensitivity and suppresses gastric cancer progression via the TP53\/SLC7A11\/ALOX12 axis. Hereditas. 2025;162(1):139.","journal-title":"Hereditas"},{"issue":"4","key":"591_CR15","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1097\/ot9.0000000000000044","volume":"10","author":"L Shuai","year":"2024","unstructured":"Shuai L. Kai Zhang,Xiaoqing Zhang,Wei Luan.Efficacy evaluation and survival analysis of the combination of oxaliplatin plus Teysuno (SOX) with immune checkpoint inhibitors in the conversion therapy of locally advanced gastric cancer. Oncol Translational Med. 2024;10(4):190\u20137.","journal-title":"Oncol Translational Med"},{"issue":"4","key":"591_CR16","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1002\/ptr.6006","volume":"32","author":"F Alam","year":"2018","unstructured":"Alam F, Khan GN, Asad MHHB. Psoralea corylifolia L: ethnobotanical, biological, and chemical aspects: a review. Phytother Res. 2018;32(4):597\u2013615.","journal-title":"Phytother Res"},{"key":"591_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.919035","volume":"13","author":"X Liu","year":"2022","unstructured":"Liu X, Zhang H, Cao J, et al. Isobavachalcone activates antitumor immunity on orthotopic pancreatic cancer model: a screening and validation. Front Pharmacol. 2022;13:919035.","journal-title":"Front Pharmacol"},{"key":"591_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2022.106262","volume":"130","author":"QX Xu","year":"2023","unstructured":"Xu QX, Wang ZJ, He ZC, Xu J, Xu W, Yang XW. Flavonoids dimers from the fruits of psoralea Corylifolia and their cytotoxicity against MCF-7 cells. Bioorg Chem. 2023;130:106262.","journal-title":"Bioorg Chem"},{"issue":"1","key":"591_CR19","first-page":"51","volume":"36","author":"C I-Hsiao","year":"2023","unstructured":"I-Hsiao C, Chien-Yu C, Yu-Hsuan L, I-Fen C. Angelicin inhibits the growth and migration of triple-negative breast cancer cells. Pak J Pharm Sci. 2023;36(1):51\u20137.","journal-title":"Pak J Pharm Sci"},{"key":"591_CR20","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.jare.2021.12.007","volume":"40","author":"Z Liang","year":"2022","unstructured":"Liang Z, Chen Y, Wang Z, et al. Protective effects and mechanisms of psoralidin against adriamycin-induced cardiotoxicity. J Adv Res. 2022;40:249\u201361.","journal-title":"J Adv Res"},{"issue":"1","key":"591_CR21","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13020-023-00740-w","volume":"18","author":"S Cheng","year":"2023","unstructured":"Cheng S, Liu S, Chen B, et al. Psoralidin inhibits osteosarcoma growth and metastasis by downregulating ITGB1 expression via the FAK and PI3K\/Akt signaling pathways. Chin Med. 2023;18(1):34.","journal-title":"Chin Med"},{"key":"591_CR22","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.biopha.2018.03.166","volume":"102","author":"Y Zhai","year":"2018","unstructured":"Zhai Y, Wang Q, Li Y, et al. The higher osteoprotective activity of psoralidin in vivo than coumestrol is attributed by its presence of an isopentenyl group and through activated PI3K\/Akt axis. Biomed Pharmacother. 2018;102:1015\u201324.","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"591_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/polym15061464","volume":"15","author":"RA Youness","year":"2023","unstructured":"Youness RA, Al-Mahallawi AM, Mahmoud FH, Atta H, Braoudaki M, Fahmy SA. Oral delivery of psoralidin by mucoadhesive surface-modified bilosomes showed boosted apoptotic and necrotic effects against breast and lung cancer cells. Polymers. 2023;15(6):1464.","journal-title":"Polymers"},{"issue":"24","key":"591_CR24","doi-asserted-by":"publisher","first-page":"4118","DOI":"10.1111\/jcmm.17997","volume":"27","author":"H Wang","year":"2023","unstructured":"Wang H, Chen W, Cui Y, Gong H, Li H. KIAA1429 protects hepatocellular carcinoma cells from ferroptotic cell death with a m6 A-dependent posttranscriptional modification of SLC7A11. J Cell Mol Med. 2023;27(24):4118\u201332.","journal-title":"J Cell Mol Med"},{"issue":"8","key":"591_CR25","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1038\/s41401-023-01062-1","volume":"44","author":"YF Wang","year":"2023","unstructured":"Wang YF, Feng JY, Zhao LN, Zhao M, Wei XF, Geng Y, et al. Aspirin triggers ferroptosis in hepatocellular carcinoma cells through restricting NF-\u03baB p65-activated SLC7A11 transcription. Acta Pharmacol Sin. 2023;44(8):1712\u201324.","journal-title":"Acta Pharmacol Sin"},{"issue":"4","key":"591_CR26","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.bbrc.2019.08.117","volume":"518","author":"K Tomita","year":"2019","unstructured":"Tomita K, Fukumoto M, Itoh K, Kuwahara Y, Igarashi K, Nagasawa T, et al. Mir-7-5p is a key factor that controls radioresistance via intracellular Fe2+ content in clinically relevant radioresistant cells. Biochem Biophys Res Commun. 2019;518(4):712\u20138.","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"591_CR27","doi-asserted-by":"publisher","first-page":"5599","DOI":"10.21873\/anticanres.12894","volume":"38","author":"J Freeman","year":"2018","unstructured":"Freeman J, Crowley PD, Foley AG, Gallagher HC, Iwasaki M, Ma D, et al. Effect of perioperative lidocaine and cisplatin on metastasis in a murine model of breast cancer surgery. Anticancer Res. 2018;38(10):5599\u2013606.","journal-title":"Anticancer Res"},{"issue":"5","key":"591_CR28","first-page":"1950","volume":"24","author":"J Li","year":"2019","unstructured":"Li J, Fu Y, Hu X, Xiong Y. Psoralidin inhibits the proliferation of human liver cancer cells by triggering cell cycle arrest, apoptosis and autophagy and inhibits tumor growth in vivo. J BUON. 2019;24(5):1950\u20135.","journal-title":"J BUON"},{"issue":"1","key":"591_CR29","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3892\/ol.2015.3861","volume":"11","author":"Z Jin","year":"2016","unstructured":"Jin Z, Yan W, Jin H, Ge C, Xu Y. Differential effect of psoralidin in enhancing apoptosis of colon cancer cells via nuclear factor-\u03baB and B-cell lymphoma-2\/B-cell lymphoma-2-associated X protein signaling pathways. Oncol Lett. 2016;11(1):267\u201372.","journal-title":"Oncol Lett"},{"issue":"1","key":"591_CR30","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S1734-1140(11)70408-X","volume":"63","author":"E Szliszka","year":"2011","unstructured":"Szliszka E, Czuba ZP, S\u0119dek \u0141, Paradysz A, Kr\u00f3l W. Enhanced TRAIL-mediated apoptosis in prostate cancer cells by the bioactive compounds Neobavaisoflavone and psoralidin isolated from psoralea corylifolia. Pharmacol Rep. 2011;63(1):139\u201348.","journal-title":"Pharmacol Rep"},{"issue":"1","key":"591_CR31","first-page":"36","volume":"21","author":"M Wang","year":"2023","unstructured":"Wang M, Tian B, Shen J, et al. Bavachin induces apoptosis in colorectal cancer cells through Gadd45a via the MAPK signaling pathway. Chin J Nat Med. 2023;21(1):36\u201346.","journal-title":"Chin J Nat Med"},{"issue":"9","key":"591_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.23401","volume":"37","author":"M Lin","year":"2023","unstructured":"Lin M, Xu Q, Luo Y, Liu G, Hou P. Bakuchiol inhibits lung cancer by modulating tumor microenvironment and the expression of PD-L1. J Biochem Mol Toxicol. 2023;37(9):e23401.","journal-title":"J Biochem Mol Toxicol"},{"key":"591_CR33","doi-asserted-by":"publisher","DOI":"10.1093\/ecam\/nen087","volume":"2011","author":"Y Wang","year":"2011","unstructured":"Wang Y, Hong C, Zhou C, Xu D, Qu HB. Screening antitumor compounds psoralen and isopsoralen from psoralea corylifolia L. seeds. Evid Based Complement Alternat Med. 2011;2011:363052.","journal-title":"Evid Based Complement Alternat Med"},{"issue":"7","key":"591_CR34","doi-asserted-by":"publisher","first-page":"e23051","DOI":"10.1002\/jbt.23051","volume":"36","author":"C Sun","year":"2022","unstructured":"Sun C, Zhao L, Wang X, et al. Psoralidin, a natural compound from psoralea corylifolia, induces oxidative damage mediated apoptosis in colon cancer cells. J Biochem Mol Toxicol. 2022;36(7):e23051.","journal-title":"J Biochem Mol Toxicol"},{"issue":"9","key":"591_CR35","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.phymed.2016.05.008","volume":"23","author":"G Ren","year":"2016","unstructured":"Ren G, Luo W, Sun W, et al. Psoralidin induced reactive oxygen species (ROS)-dependent DNA damage and protective autophagy mediated by NOX4 in breast cancer cells. Phytomedicine. 2016;23(9):939\u201347.","journal-title":"Phytomedicine"},{"issue":"1","key":"591_CR36","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1515\/hmbci-2021-0028","volume":"43","author":"D Amani","year":"2021","unstructured":"Amani D, Shakiba E, Motaghi E, Alipanah H, Jalalpourroodsari M, Rashidi M. Psoralidin exerts anti-tumor, anti-angiogenic, and immunostimulatory activities in 4T1 tumor-bearing balb\/c mice. Horm Mol Biol Clin Investig. 2021;43(1):71\u20139.","journal-title":"Horm Mol Biol Clin Investig"},{"issue":"2","key":"591_CR37","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s10120-024-01574-7","volume":"28","author":"H Wang","year":"2025","unstructured":"Wang H, Lu C, Zhou H, Zhao X, Huang C, Cheng Z, et al. Synergistic effects of Dihydroartemisinin and cisplatin on inducing ferroptosis in gastric cancer through GPX4 inhibition. Gastric Cancer. 2025;28(2):187\u2013210.","journal-title":"Gastric Cancer"},{"issue":"1","key":"591_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-023-01564-1","volume":"9","author":"H Qi","year":"2023","unstructured":"Qi H, Shi H, Yan M, Zhao L, Yin Y, Tan X, et al. Ammonium tetrathiomolybdate relieves oxidative stress in cisplatin-induced acute kidney injury via NRF2 signaling pathway. Cell Death Discov. 2023;9(1):259.","journal-title":"Cell Death Discov"},{"key":"591_CR39","doi-asserted-by":"publisher","first-page":"177609","DOI":"10.1016\/j.ejphar.2025.177609","volume":"997","author":"AA Raouf","year":"2025","unstructured":"Raouf AA, El-Kadem AH, Sokar SS, Oraby MA, El-Shitany NA. Cilostazol attenuates cisplatin-induced acute liver injury by targeting the SIRT1\/AMPK\/PGC-1\u03b1 signaling pathway, with an impact on miRNA-34a. Eur J Pharmacol. 2025;997:177609.","journal-title":"Eur J Pharmacol"},{"key":"591_CR40","doi-asserted-by":"publisher","first-page":"156443","DOI":"10.1016\/j.phymed.2025.156443","volume":"144","author":"S Jiang","year":"2025","unstructured":"Jiang S, Xu X, Deng C, Tian J, Wang X, Liu L, Liu X, Zhou K, He W, Yang Y, Ni Y. Pleiotropic role of TLR2-mediated signaling in the protection of psoralidin against sepsis-induced acute lung injury. Phytomedicine. 2025;144:156443.","journal-title":"Phytomedicine"},{"key":"591_CR41","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.freeradbiomed.2023.04.006","volume":"204","author":"Y Yang","year":"2023","unstructured":"Yang Y, Lei W, Qian L, Zhang S, Yang W, Lu C, et al. Activation of NR1H3 signaling pathways by psoralidin attenuates septic myocardial injury. Free Radic Biol Med. 2023;204:8\u201319.","journal-title":"Free Radic Biol Med"},{"issue":"11","key":"591_CR42","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1038\/s41418-022-01008-w","volume":"29","author":"Y Wang","year":"2022","unstructured":"Wang Y, Zheng L, Shang W, Yang Z, Li T, Liu F, et al. Wnt\/beta-catenin signaling confers ferroptosis resistance by targeting GPX4 in gastric cancer. Cell Death Differ. 2022;29(11):2190\u2013202.","journal-title":"Cell Death Differ"},{"issue":"6","key":"591_CR43","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.ccell.2019.04.002","volume":"35","author":"B Hassannia","year":"2019","unstructured":"Hassannia B, Vandenabeele P, Vanden Berghe T. Targeting ferroptosis to iron out cancer. Cancer Cell. 2019;35(6):830\u201349.","journal-title":"Cancer Cell"},{"issue":"4","key":"591_CR44","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1111\/jcmm.17171","volume":"26","author":"R Xiao","year":"2022","unstructured":"Xiao R, Wang S, Guo J, Liu S, Ding A, Wang G, et al. Ferroptosis-related gene NOX4, CHAC1 and HIF1A are valid biomarkers for stomach adenocarcinoma. J Cell Mol Med. 2022;26(4):1183\u201393.","journal-title":"J Cell Mol Med"},{"issue":"4","key":"591_CR45","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3233\/CBM-230114","volume":"39","author":"W Pei","year":"2024","unstructured":"Pei W, Jiang M, Liu H, Song J, Hu J. The prognostic and antitumor roles of key genes of ferroptosis in liver hepatocellular cancer and stomach adenocarcinoma. Cancer Biomark. 2024;39(4):335\u201347.","journal-title":"Cancer Biomark"},{"issue":"2","key":"591_CR46","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41388-022-02537-x","volume":"42","author":"D Li","year":"2023","unstructured":"Li D, Wang Y, Dong C, Chen T, Dong A, Ren J, et al. CST1 inhibits ferroptosis and promotes gastric cancer metastasis by regulating GPX4 protein stability via OTUB1. Oncogene. 2023;42(2):83\u201398.","journal-title":"Oncogene"},{"issue":"10","key":"591_CR47","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1158\/0008-5472.CAN-22-1999","volume":"83","author":"Q Hu","year":"2023","unstructured":"Hu Q, Dai J, Zhang Z, Yu H, Zhang J, Zhu X, et al. ASS1-mediated reductive carboxylation of cytosolic glutamine confers ferroptosis resistance in cancer cells. Cancer Res. 2023;83(10):1646\u201365.","journal-title":"Cancer Res"},{"issue":"1","key":"591_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s11658-021-00271-y","volume":"26","author":"D Fu","year":"2021","unstructured":"Fu D, Wang C, Yu L, Yu R. Induction of ferroptosis by ATF3 elevation alleviates cisplatin resistance in gastric cancer by restraining Nrf2\/Keap1\/xCT signaling. Cell Mol Biol Lett. 2021;26(1):26.","journal-title":"Cell Mol Biol Lett"},{"issue":"1","key":"591_CR49","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nchembio.2239","volume":"13","author":"S Doll","year":"2017","unstructured":"Doll S, Proneth B, Tyurina YY, et al. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat Chem Biol. 2017;13(1):91\u20138.","journal-title":"Nat Chem Biol"},{"key":"591_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.prostaglandins.2019.106363","volume":"144","author":"H Kuwata","year":"2019","unstructured":"Kuwata H, Hara S. Role of acyl-CoA synthetase ACSL4 in arachidonic acid metabolism. Prostaglandins Other Lipid Mediat. 2019;144:106363.","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"51","key":"591_CR51","doi-asserted-by":"publisher","first-page":"32433","DOI":"10.1073\/pnas.2006828117","volume":"117","author":"JY Lee","year":"2020","unstructured":"Lee JY, Nam M, Son HY, Hyun K, Jang SY, Kim JW, et al. Polyunsaturated fatty acid biosynthesis pathway determines ferroptosis sensitivity in gastric cancer. Proc Natl Acad Sci U S A. 2020;117(51):32433\u201342.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"591_CR52","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/j.tcb.2023.05.003","volume":"33","author":"LE Pope","year":"2023","unstructured":"Pope LE, Dixon SJ. Regulation of ferroptosis by lipid metabolism. Trends Cell Biol. 2023;33(12):1077\u201387.","journal-title":"Trends Cell Biol"},{"key":"591_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.175497","volume":"941","author":"J Lee","year":"2023","unstructured":"Lee J, Shin D, Roh JL. Lipid metabolism alterations and ferroptosis in cancer: paving the way for solving cancer resistance. Eur J Pharmacol. 2023;941:175497.","journal-title":"Eur J Pharmacol"},{"key":"591_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102857","volume":"66","author":"P Kong","year":"2023","unstructured":"Kong P, Yang M, Wang Y, Yu KN, Wu L, Han W. Ferroptosis triggered by STAT1- IRF1-ACSL4 pathway was involved in radiation-induced intestinal injury. Redox Biol. 2023;66:102857.","journal-title":"Redox Biol"},{"key":"591_CR55","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.canlet.2020.12.019","volume":"502","author":"J Chen","year":"2021","unstructured":"Chen J, Ding C, Chen Y, et al. Acsl4 reprograms fatty acid metabolism in hepatocellular carcinoma via c-Myc\/SREBP1 pathway. Cancer Lett. 2021;502:154\u201365.","journal-title":"Cancer Lett"},{"issue":"11","key":"591_CR56","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1158\/0008-5472.CAN-23-2491","volume":"84","author":"Y Qiu","year":"2024","unstructured":"Qiu Y, Wang X, Sun Y, Jin T, Tang R, Zhou X, et al. Acsl4-mediated membrane phospholipid remodeling induces integrin \u03b21 activation to facilitate Triple-Negative breast cancer metastasis. Cancer Res. 2024;84(11):1856\u201371.","journal-title":"Cancer Res"},{"key":"591_CR57","doi-asserted-by":"publisher","first-page":"110629","DOI":"10.1016\/j.intimp.2023.110629","volume":"122","author":"P Chen","year":"2023","unstructured":"Chen P, Wang D, Xiao T, Gu W, Yang H, Yang M, Wang H. ACSL4 promotes ferroptosis and M1 macrophage polarization to regulate the tumorigenesis of nasopharyngeal carcinoma. Int Immunopharmacol. 2023;122:110629.","journal-title":"Int Immunopharmacol"},{"key":"591_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2021.114718","volume":"192","author":"YS Kwon","year":"2021","unstructured":"Kwon YS, Lee MG, Baek J, Kim NY, Jang H, Kim S. Acyl-CoA synthetase-4 mediates radioresistance of breast cancer cells by regulating FOXM1. Biochem Pharmacol. 2021;192:114718.","journal-title":"Biochem Pharmacol"},{"issue":"9","key":"591_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-07098-3","volume":"15","author":"X Zhao","year":"2024","unstructured":"Zhao X, Zhao Z, Li B, Huan S, Li Z, Xie J, et al. ACSL4-mediated lipid rafts prevent membrane rupture and inhibit immunogenic cell death in melanoma. Cell Death Dis. 2024;15(9):695.","journal-title":"Cell Death Dis"},{"issue":"2","key":"591_CR60","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.cell.2024.10.047","volume":"188","author":"Y Wang","year":"2025","unstructured":"Wang Y, Hu M, Cao J, Wang F, Han JR, Wu TW, Li L, Yu J, Fan Y, Xie G, Lian H, Cao Y, Naowarojna N, Wang X, Zou Y. ACSL4 and polyunsaturated lipids support metastatic extravasation and colonization. Cell. 2025;188(2):412\u2013e42927.","journal-title":"Cell"},{"issue":"8","key":"591_CR61","doi-asserted-by":"publisher","first-page":"625","DOI":"10.5152\/tjg.2024.23526","volume":"35","author":"X Zheng","year":"2024","unstructured":"Zheng X, Liu J, Hu W, Jiang B, Zhou X, Zhang M, et al. Curcumin induces autophagy-mediated ferroptosis by targeting the PI3K\/AKT\/mTOR signaling pathway in gastric cancer. Turk J Gastroenterol. 2024;35(8):625\u201333.","journal-title":"Turk J Gastroenterol"},{"key":"591_CR62","doi-asserted-by":"publisher","DOI":"10.1177\/09603271231216963","volume":"42","author":"M Xia","year":"2023","unstructured":"Xia M, Wu Y, Zhu H, Duan W. Tanshinone I induces ferroptosis in gastric cancer cells via the KDM4D\/p53 pathway. Hum Exp Toxicol. 2023;42:9603271231216963.","journal-title":"Hum Exp Toxicol"},{"issue":"1","key":"591_CR63","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.bja.2017.12.043","volume":"121","author":"MZ Johnson","year":"2018","unstructured":"Johnson MZ, Crowley PD, Foley AG, Xue C, Connolly C, Gallagher HC, et al. Effect of perioperative lidocaine on metastasis after sevoflurane or ketamine-xylazine anaesthesia for breast tumour resection in a murine model. Br J Anaesth. 2018;121(1):76\u201385.","journal-title":"Br J Anaesth"},{"issue":"2","key":"591_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2023.166941","volume":"1870","author":"ZR Kang","year":"2024","unstructured":"Kang ZR, Jiang S, Han JX, Gao Y, Xie Y, Chen J, et al. Deficiency of BCAT2-mediated branched-chain amino acid catabolism promotes colorectal cancer development. Biochimica et Biophysica Acta (BBA). 2024;1870(2):166941.","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"issue":"6","key":"591_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2024.167250","volume":"1870","author":"SJ Lee","year":"2024","unstructured":"Lee SJ, Jeon SH, Cho S, Kim CM, Yoo JK, Oh SH, et al. hsa-miR-CHA2, a novel microrna, exhibits anticancer effects by suppressing Cyclin E1 in human non-small cell lung cancer cells. Biochimica et Biophysica Acta (BBA). 2024;1870(6):167250.","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"key":"591_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.123276","volume":"643","author":"MS Khan","year":"2023","unstructured":"Khan MS, Gowda BHJ, Nasir N, Wahab S, Pichika MR, Sahebkar A, et al. Advancements in dextran-based nanocarriers for treatment and imaging of breast cancer. Int J Pharm. 2023;643:123276.","journal-title":"Int J Pharm"},{"issue":"1","key":"591_CR67","doi-asserted-by":"publisher","first-page":"7","DOI":"10.15212\/bioi-2022-0025","volume":"4","author":"S He","year":"2023","unstructured":"He S, Xiao X, Lei R, et al. Establishment of breast phyllodes tumor cell lines preserving the features of phyllodes tumors. BIO Integr. 2023;4(1):7\u201317.","journal-title":"BIO Integr"}],"container-title":["Hereditas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-025-00591-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41065-025-00591-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-025-00591-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T22:28:46Z","timestamp":1762295326000},"score":1,"resource":{"primary":{"URL":"https:\/\/hereditasjournal.biomedcentral.com\/articles\/10.1186\/s41065-025-00591-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,4]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["591"],"URL":"https:\/\/doi.org\/10.1186\/s41065-025-00591-5","relation":{},"ISSN":["1601-5223"],"issn-type":[{"value":"1601-5223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,4]]},"assertion":[{"value":"14 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal study was approved by the Ethics Committee of The First Hospital of Nanchang (Approval No. 2022011-007).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"223"}}